Evidence map›Paper›PMID 34065718›Full record

ArticleJournal of personalized medicine2021

Three-Year Follow-Up of Laser In Situ Keratomileusis Treatments for Myopia: Multi-Center Cohort Study in Korean Population.

Jae-Yong Kim, Hun Lee, Choun-Ki Joo, Joon-Young Hyon, Tae-Im Kim, Jin-Hyoung Kim, Jin-Kuk Kim, Eun-Young Cho, Ji-Eun Choi, Na-Rae Lee and 1 more

Abstract read
In one paragraph

Article in Journal of personalized medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jae-Yong KimDepartment of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.ORCID 0000-0001-8571-8350
Hun LeeDepartment of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.ORCID 0000-0001-7225-6580
Choun-Ki JooDepartment of Ophthalmology and Visual Science, Kangnam St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Joon-Young HyonDepartment of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam 13620, Korea.
Tae-Im KimDepartment of Ophthalmology, Institute of Vision Research, Corneal Dystrophy Research Institute, Yonsei University College of Medicine, Seoul 03722, Korea.
Jin-Hyoung KimDepartment of Ophthalmology, Ilsan Paik Hospital, Inje University of Korea, Koyang 10380, Korea.
Jin-Kuk KimB&VIIT Eye Center, Seoul 06615, Korea.
Eun-Young ChoB&VIIT Eye Center, Seoul 06615, Korea.
Ji-Eun ChoiNational Evidence-Based Healthcare Collaborating Agency, Seoul 04554, Korea.
Na-Rae LeeNational Evidence-Based Healthcare Collaborating Agency, Seoul 04554, Korea.
Hung-Won TchahDepartment of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.

Funding

Asan Institute for Life Sciences, Asan Medical Center 2019IP0813Ministry of Education, Science and Technology 2020R1F1A1073627National Research Foundation of Korea 2018R1D1A1B0704
6 · The paper itself

Abstract

This multi-center cohort study included 3401 myopic laser in situ keratomileusis (LASIK) procedures conducted in 1756 myopia patients between 2002 and 2005. Pre- and postoperative uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), and manifest refraction spherical equivalent (SE) were recorded. Factors predicting low postoperative efficacy (defined as a postoperative UCVA < 0.5) were identified using univariate and multivariate logistic regression analysis. Compared with 1 month postoperatively, logMAR UCVA at 3 months postoperatively was significantly decreased (

Indexed as

efficacylaser in situ keratomileusissafety

Identifiers

PMID34065718
PMCPMC8156820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.